
Journal of Medicinal Chemistry p. 425 - 432 (1993)
Update date:2022-09-26
Topics:
Burke Jr.
Lim
Marquez
Li
Bolen
Stefanova
Horak
A study was undertaken to prepare inhibitors of the lymphocyte protein- tyrosine kinase p56(lck). Using the known p56(lck) inhibitor 3,4-dihydroxy- α-cyanocinnamamide (4) as a lead compound, bicyclic analogues were designed as conformationally constrained
View MoreWuhan Shangrisyn chemicals Technology Co.,Ltd(expird)
Contact:+86-027-84466317 __ +86-15387123698
Address:wuhan - china
Zouping Fuhai Technology Development Co., Ltd.
Contact:+0532-86934525 18660293207
Address:jiuhu town industrial park Zouping County,bingzhou Provincejiuhu town industrial park
KINHENG CHEMICAL(SHANGHAI)CO., LTD.
Contact:+8621-60490170
Address:Room401, No.28,Lane 189, Yangshupu Rd. Shanghai, China.
Qingdao S. H. Huanyu Imp. & Exp. Co., Ltd.
Contact:86-532-88250866
Address:Room 615, World Trade Centre Building B, Hongkong Middle Roda 6#, Qingdao, Shandong, China
Contact:027-87677569
Address:Room 2203, yujingmingmen Buidling One, xiongchu Road, wuhan city, hubei province, China
Doi:10.1021/ol202751s
(2011)Doi:10.1007/s00044-011-9857-0
(2012)Doi:10.1021/jm00080a028
(1992)Doi:10.1055/s-1991-26464
(1991)Doi:10.1021/jo00016a001
(1991)Doi:10.1021/ja01486a058
(1960)